References
Berry RS, Gullapalli RR, Wu J, Morris K, Hanson JA (2014) Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation. Virchows Arch 465:241–245
Bioulac-Sage P, Taouji S, Le Bail B, Possenti L, Balabaud C (2013) Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens. Int J Hepatol 2013:417323
Rebouissou S, Couchy G, Libbrecht L et al (2008) The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 49:61–71
Arnason T, Fleming KE, Wanless IR (2013) Peritumoral hyperplasia of the liver: a response to portal vein invasion by hypervascular neoplasms. Histopathology 62:458–464
Pilati C, Letouzé E, Nault JC et al (2014) Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. Cancer Cell 25:428–441
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Balabaud, C., Bioulac-Sage, P. Glutamine synthetase interpretation in hepatocellular adenoma. Virchows Arch 465, 495–496 (2014). https://doi.org/10.1007/s00428-014-1649-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-014-1649-8